Hypha's Q2 2024 Newsletter
Hypha Discovery Ltd
![Hypha Discovery Ltd]()
Hypha Discovery Ltd
Experts in synthesis, purification and ID of metabolites and derivatives for pharma and agrochemical companies worldwide
Focus on N-glucuronidation
N-glucuronides may emerge as disproportionate metabolites due to interspecies variability and higher rates of?N-glucuronidation in humans. This is particularly relevant for some aromatic?N-heterocycles metabolised by UGT1A4 and UGT2B10.?
In this newsletter we look at two major?N-glucuronides formed by UGT1A4 that were needed for further studies. Microbial biotransformation was used to access the N-glucuronide of camonsertib, and a switch from human liver S9 to late-stage chemical synthesis enabled gram amounts of the N-glucuronide of LEO compound 1 to be made.
Read the full newsletter here.